In a kidney transplant recipient on prednisone 5 mg daily with HbA1c 9.6% while using insulin glargine (Lantus) 22 U daily and regular insulin 5 U before each meal, what is an appropriate treatment plan to achieve glycemic control?

Treatment Plan for Diabetic Control in a Kidney Transplant Recipient

Immediate Insulin Regimen Intensification Required

Your patient's current insulin regimen is profoundly inadequate for an A1c of 9.6%, and immediate intensification to a structured basal-bolus regimen is essential. The total daily dose of 37 units (22 units Lantus + 15 units regular insulin) is insufficient, and the use of regular insulin three times daily without proper titration represents suboptimal management.1

---

Step 1: Optimize Basal Insulin (Lantus)

Increase Basal Dose Aggressively

• Increase Lantus from 22 units to 30-35 units once daily (targeting approximately 0.3-0.4 units/kg/day given the A1c of 9.6%).2, 3
• Administer at the same time each evening (preferably 8-10 PM) for consistent 24-hour coverage.2

Titration Protocol

• Increase by 4 units every 3 days if fasting glucose remains ≥180 mg/dL.2, 3
• Increase by 2 units every 3 days if fasting glucose is 140-179 mg/dL.2, 3
• Target fasting glucose: 80-130 mg/dL.2, 3
• Stop escalating basal insulin when dose approaches 0.5 units/kg/day (approximately 40-45 units for most adults); beyond this threshold, add prandial insulin rather than continuing basal escalation to avoid "overbasalization."2, 3

---

Step 2: Replace Regular Insulin with Structured Prandial Coverage

Discontinue Current Sliding Scale Approach

Immediately stop the current regimen of regular insulin 5 units three times daily. This fixed-dose approach without proper carbohydrate matching or correction dosing is ineffective.1, 2

Initiate Rapid-Acting Insulin (Preferred) or Continue Regular Insulin (If Cost-Prohibitive)

Option A: Rapid-Acting Insulin (Lispro, Aspart, or Glulisine) - PREFERRED

• Start with 6-8 units before each of the three main meals (breakfast, lunch, dinner).2, 3
• Administer 0-15 minutes before meals for optimal postprandial control.2
• Titrate each meal dose by 2 units every 3 days based on 2-hour postprandial glucose readings.2, 3
• Target postprandial glucose <180 mg/dL.2, 3

Option B: Regular Insulin (If Rapid-Acting Not Available)

• Start with 6-8 units before each meal, administered 30-45 minutes before eating.1
• Titrate similarly based on postprandial glucose patterns.2

Add Correction Insulin Protocol

• Add 2 units for pre-meal glucose >250 mg/dL.2
• Add 4 units for pre-meal glucose >350 mg/dL.2
• These correction doses are in addition to scheduled prandial insulin.2

---

Step 3: Address Prednisone-Induced Insulin Resistance

Recognize Steroid Impact

Prednisone 5 mg daily significantly increases insulin requirements, particularly affecting afternoon and evening glucose levels due to peak steroid effect 4-12 hours after morning dosing.1

Adjust for Steroid Effect

• Expect 40-60% higher insulin requirements compared to non-transplant patients.1
• Prioritize afternoon/evening prandial insulin doses (lunch and dinner may require 8-10 units each after titration).1
• Monitor for nocturnal hypoglycemia (60% of hypoglycemic episodes occur overnight in transplant recipients on insulin).4

Consider Steroid Dose Reduction (If Feasible)

• Coordinate with transplant team to assess whether prednisone can be reduced below 5 mg daily, as lower steroid doses significantly improve glucose tolerance.1
• Do NOT discontinue steroids entirely due to rejection risk.1

---

Step 4: Monitoring and Safety Protocols

Daily Glucose Monitoring During Titration

• Check fasting glucose every morning to guide basal insulin adjustments.2, 3
• Check pre-meal glucose before each meal to calculate correction doses.2
• Check 2-hour postprandial glucose after meals to guide prandial insulin titration.2, 3
• Check bedtime glucose to assess overall daily pattern.2

Hypoglycemia Management

• Treat glucose <70 mg/dL immediately with 15 grams fast-acting carbohydrate.2
• Reduce implicated insulin dose by 10-20% if unexplained hypoglycemia occurs.2, 3
• Provide glucagon emergency kit and educate patient on recognition/treatment.2

A1c Monitoring

• Recheck A1c every 3 months during intensive titration phase.1
• Target A1c <7.0% (or <6.5% if achievable without significant hypoglycemia).1

---

Step 5: Consider Adjunctive Oral Agents (If Not Already Prescribed)

Metformin (First-Line Addition)

• Start metformin 500-1000 mg twice daily (titrate to 2000 mg/day) if not contraindicated by renal function.1, 2
• Check eGFR before initiation; metformin is generally safe in transplant recipients with stable kidney function (eGFR >30 mL/min).1, 5
• Metformin reduces insulin requirements by 20-30% and provides complementary glucose-lowering without hypoglycemia risk.2

DPP-4 Inhibitors (Safe in Transplant Recipients)

• Consider sitagliptin 100 mg daily or vildagliptin 50 mg twice daily as an alternative or addition to metformin.5
• No drug interactions with immunosuppressants (tacrolimus, cyclosporine, mycophenolate).5
• Lower hypoglycemia risk compared to sulfonylureas.5
• Provides additional 0.5-0.8% A1c reduction when added to insulin.5

Avoid Certain Agents

• Do NOT use SGLT2 inhibitors in transplant recipients due to increased urinary tract infection risk and uncertain safety profile.1, 5
• Avoid sulfonylureas due to high hypoglycemia risk when combined with insulin in transplant recipients.1, 5
• Use pioglitazone cautiously (if at all) due to fluid retention risk, though one study showed efficacy in transplant recipients.5

---

Step 6: Patient Education Essentials

Critical Teaching Points

• Insulin injection technique and site rotation to prevent lipohypertrophy.2
• Hypoglycemia recognition and treatment (symptoms, <70 mg/dL threshold, 15-gram carbohydrate rule).2
• Sick-day management: continue insulin even if not eating, check glucose every 4 hours, maintain hydration.2
• Glucose monitoring: at least four daily measurements during titration phase.2
• Ketone testing when glucose >300 mg/dL with nausea/vomiting (though less common in type 2 diabetes).2

---

Step 7: Expected Outcomes and Follow-Up

Anticipated A1c Reduction

• Expect 2-3% A1c reduction (from 9.6% to approximately 6.5-7.5%) over 3-6 months with proper basal-bolus therapy.2, 6
• 68% of patients achieve mean glucose <140 mg/dL with structured basal-bolus regimens versus 38% with sliding-scale alone.2

Follow-Up Schedule

• Weekly phone contact during first month to review glucose logs and adjust insulin doses.2, 3
• In-person visit at 1 month to assess progress and reinforce education.2
• A1c recheck at 3 months; if A1c remains >7%, further intensify prandial insulin or add GLP-1 receptor agonist.2, 3
• Coordinate with transplant team regarding immunosuppression adjustments and potential steroid tapering.1

---

Critical Pitfalls to Avoid

1. Do NOT continue sliding-scale insulin as monotherapy—this approach is condemned by all major diabetes guidelines and leads to dangerous glucose fluctuations.1, 2

2. Do NOT delay prandial insulin addition—an A1c of 9.6% clearly indicates need for both basal and prandial coverage from the outset.2, 3

3. Do NOT increase basal insulin beyond 0.5 units/kg/day without addressing postprandial hyperglycemia—this causes "overbasalization" with increased hypoglycemia risk.2, 3

4. Do NOT ignore steroid-induced insulin resistance—transplant recipients require 40-60% higher insulin doses than non-transplant patients.1

5. Do NOT use A1c alone for monitoring in transplant recipients—anemia and kidney impairment may affect A1c validity; rely heavily on glucose monitoring.1

6. Do NOT administer rapid-acting insulin at bedtime as sole correction dose—this markedly increases nocturnal hypoglycemia risk.2

---

Summary Algorithm

For a kidney transplant recipient on prednisone 5 mg daily with A1c 9.6%:

1. Increase Lantus to 30-35 units once daily → titrate by 2-4 units every 3 days targeting fasting glucose 80-130 mg/dL.2, 3

2. Replace regular insulin 5 units TID with structured prandial insulin: Start 6-8 units rapid-acting insulin before each meal → titrate by 2 units every 3 days targeting postprandial glucose <180 mg/dL.2, 3

3. Add correction insulin protocol: 2 units for pre-meal glucose >250 mg/dL, 4 units for >350 mg/dL.2

4. Consider metformin 1000 mg BID (if eGFR >30) or DPP-4 inhibitor to reduce insulin requirements.1, 2, 5

5. Monitor glucose 4-6 times daily during titration; recheck A1c at 3 months.2, 3

6. Coordinate with transplant team regarding potential steroid dose reduction.1